Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Lestelle (Lyon, France), M. Nasser (Lyon, France), A. Roux (Suresnes, France), S. Hirschi (Strasbourg, France), L. Wemeau (Lille, France), G. Prévot (Toulouse, France), D. Rotzinger (Lausanne, Switzerland), S. Si-Mohamed (Lyon, France), V. Bunel (Paris, France), E. Gomez (Nancy, France), L. Sohier (Lorient, France), H. Morisse Pradier (Rouen, France), M. Reynaud Gaubert (Marseille, France), A. Gondouin (Besançon, France), R. Lazor (Lausanne, Switzerland), Y. Uzunhan (Bobigny, France), P. Rigaud (Paris, France), M. Colombat (Toulouse, France), C. Beigelman (Lausanne, Switzerland), V. Cottin (Lyon, Switzerland). Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome. 4235

Member's Comments

No comment yet.

Related content which might interest you: Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Physical Training Improves Lung Function and Mechanics and Pulmonary and Systemic Immune Response in Eutrophic Women Source: Virtual Congress 2020 – Novel insights into exercise training Year: 2020 Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019 Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Does a Tailored Intervention to Promote Adherence in Patients with Chronic Lung Disease Affect Exacerbations? Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Red Blood Cell Distribution Width as a potential predictor of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 The Use of Respiratory Sounds for Automated Detection of Obstructive Pulmonary Disease: Do Lung Sound Labels Provide Value? Source: International Congress 2017 – Lung function testing in different patient categories Year: 2017 Molecular Markers of Telomere Dysfunction and Senescence are Common Findings in the Usual Interstitial Pneumonia Pattern of Lung Fibrosis Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias Year: 2018 Patterns of Oxygen Pulse Response to Incremental Exercise in Patients with Chronic Obstructive Pulmonary Disease – An Observational Study Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases Year: 2017 Natural Variability of Clinically Measured Lung Clearance Index in Children with Cystic Fibrosis Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 Metered Cryospray Modulates Bronchial Epithelial Gene Expression in Patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Interventional pulmonology: unity in diversity Year: 2020 Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019 Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Cell Therapy in Patients with Advanced Chronic Obstructive Pulmonary Disease:  3 and 6 months follow up of Six Minute Walk Test, Quality of life and Pulmonary Function Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017 Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF) Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019